respiratori
virus
repres
one
substanti
infecti
diseas
burden
human
popul
today
particular
season
pandem
influenza
virus
pose
persist
threat
public
health
worldwid
recent
year
advanc
techniqu
use
experiment
research
provid
mean
better
understand
mechan
pathogenesi
transmiss
respiratori
virus
thu
accur
model
infect
laboratori
briefli
review
model
system
use
studi
influenza
viru
infect
focu
particularli
recent
advanc
increas
knowledg
formid
respiratori
pathogen
respiratori
ill
common
type
ailment
report
otherwis
healthi
adult
children
respiratori
virus
often
culprit
sever
ill
display
acut
respiratori
infect
rang
minor
common
cold
symptom
lifethreaten
diseas
depend
greatli
etiolog
agent
health
statu
host
unfortun
respiratori
infect
lethal
outcom
familiar
develop
countri
especi
children
viral
infect
contribut
case
comparison
fatal
respiratori
infect
develop
countri
less
common
incid
seriou
complic
vulner
popul
underli
health
condit
young
elderli
consider
averag
respiratori
ill
report
three
five
time
per
adult
per
year
five
nine
time
per
child
per
year
result
work
day
lost
school
day
miss
per
individu
per
year
viral
infect
respiratori
tract
restrict
upper
respiratori
tract
urt
lower
respiratori
tract
lrt
altern
urt
lrt
may
target
extrapulmonari
tissu
may
involv
eg
gastrointestin
central
nervou
system
viral
infect
urt
often
result
lrt
involv
either
direct
spread
viru
indirectli
via
neurogen
link
circul
immun
mediat
caus
physiolog
chang
asthmat
exacerb
bacteri
coinfect
common
identifi
approxim
pediatr
lrt
infect
urt
infect
may
manifest
sinus
otiti
media
pharyng
tonsil
caus
local
symptom
rhinorrhea
nasal
congest
sneez
cough
sore
throat
main
pathogen
respons
common
cold
symptom
rhinovirus
rv
coronavirus
cov
adenovirus
adv
lrt
infect
often
result
seriou
syndrom
bronchiti
bronchiol
pneumonia
symptom
includ
fever
weak
cough
wheez
short
breath
children
adult
frequent
etiolog
lrt
viral
infect
respiratori
syncyti
viru
rsv
parainfluenza
viru
piv
influenza
viru
particular
concern
global
public
health
emerg
highli
infecti
transmiss
respiratori
pathogen
potenti
overwhelm
immunolog
popul
recent
year
least
two
respiratori
pathogen
emerg
human
present
consider
public
health
threat
healthi
individu
vulner
popul
sever
acut
respiratori
syndrom
viru
sarscov
influenza
viru
sarscov
caus
lrt
diseas
infam
outbreak
start
within
week
spread
countri
result
case
mortal
impact
pandem
influenza
virus
differ
substanti
magnitud
sever
wherea
season
influenza
virus
may
caus
symptomat
respiratori
ill
world
popul
relat
death
annual
recent
pandem
viru
spread
across
least
countri
consid
mild
compar
pandem
result
estim
million
death
worldwid
sinc
highli
pathogen
avian
influenza
hpai
virus
caus
hundr
human
respiratori
infect
high
fatal
rate
approxim
http
cumulativetablearchivesenindexhtml
although
virus
readili
transmiss
among
human
current
form
emerg
highli
transmiss
viru
would
like
caus
pandem
review
focu
specif
influenza
virus
everpres
everchang
public
health
threat
respiratori
pathogen
influenza
virus
shed
infect
individu
respiratori
secret
expel
breath
talk
cough
sneez
transmiss
viru
suscept
host
occur
sever
way
direct
contact
indirect
contact
fomit
ii
droplet
transmiss
larg
particl
contact
person
conjunctiva
respiratori
mucosa
iii
droplet
nuclei
transmiss
also
known
airborn
aerosol
transmiss
fine
particl
capabl
prolong
suspens
air
inhal
mode
transmiss
mutual
exclus
rel
predomin
differ
mode
transmiss
depend
sever
condit
includ
environment
set
temperatur
humid
infect
rate
mani
virus
associ
respiratori
ill
display
distinct
season
variat
particularli
temper
region
world
although
outbreak
intens
vari
year
year
gener
trend
predict
especi
true
season
influenza
virus
peak
predomin
winter
month
temper
climat
pandem
influenza
viru
infect
except
pattern
like
lack
immun
emerg
novel
strain
multipl
theori
propos
explain
season
trend
respiratori
infect
includ
chang
host
suscept
viru
stabil
infect
indoor
crowd
consist
season
trend
envelop
virus
influenza
viru
demonstr
increas
viabil
low
humid
level
cooler
temperatur
howev
tropic
region
world
climat
fluctuat
minim
warm
humid
climat
typic
influenza
case
detect
yearround
biannual
peak
thu
factor
thought
facilit
transmiss
certain
respiratori
virus
temper
region
winter
month
may
contribut
transmiss
tropic
climat
make
obviou
one
theori
satisfactorili
explain
global
respiratori
infect
transmiss
pattern
mani
unansw
question
regard
respiratori
virus
caus
diseas
transmit
among
peopl
necessari
model
respiratori
infect
laboratori
briefli
review
influenza
viru
infect
model
system
focu
given
recent
innov
model
influenza
viru
infect
anim
improv
model
system
increas
knowledg
influenza
virus
affect
public
health
throughout
world
model
infect
laboratori
fundament
tool
infecti
diseas
experiment
research
critic
understand
mechan
viru
infect
transmiss
host
diseas
immun
respons
model
system
divid
vitro
ex
vivo
vivo
categori
increas
complex
particular
applic
limit
tabl
immort
cell
line
repres
human
airway
notabl
human
bronchial
adenocarcinoma
epitheli
continu
cell
line
grown
transwel
membran
becom
highli
polar
tight
junction
separ
distinct
apic
basolater
surfac
provid
opportun
assess
local
viru
attach
entri
releas
primari
human
airway
epitheli
cell
use
mani
applic
also
provid
addit
complex
heterogen
cell
popul
includ
ciliat
noncili
mucinsecret
goblet
cell
basal
epitheli
cell
studi
use
primari
human
airway
cell
cultur
nasal
adenoid
tracheal
bronchial
alveolar
tissu
sampl
differenti
airliquid
interfac
further
understand
influenza
viru
infect
tissu
tropism
properti
host
immun
respons
specif
region
within
respiratori
tract
exampl
human
influenza
virus
shown
infect
noncili
cell
express
sialic
acid
glycan
wherea
avian
influenza
virus
infect
ciliat
cell
express
sialic
acid
glycan
primari
human
tracheobronchi
epitheli
cultur
addit
respiratori
cell
cultur
primari
human
corneal
conjunctiv
cell
cultur
use
vitro
model
ocular
infect
reveal
potenti
mechan
ocular
tropism
influenza
virus
also
respiratori
infect
may
develop
ocular
inocul
ex
vivo
human
airway
tissu
serv
snapshot
airway
epitheli
environ
within
human
host
use
demonstr
highli
transmiss
season
influenza
virus
attach
urt
tissu
readili
avian
influenza
virus
capabl
sustain
transmiss
human
human
urt
tissu
capabl
support
avian
influenza
viru
replic
avail
human
ex
vivo
tissu
sampl
often
limit
therefor
experi
may
conduct
use
tissu
deriv
appropri
anim
model
consider
attent
given
distribut
receptor
use
influenza
virus
within
respiratori
tract
variou
anim
model
compar
human
pattern
viral
attach
pva
observ
human
ex
vivo
respiratori
tract
tissu
similar
ferret
pig
human
influenza
virus
ferret
pig
cat
avian
influenza
virus
ferret
pig
tracheal
ex
vivo
tissu
use
assess
pva
also
replic
influenza
virus
ciliari
activ
link
destruct
ciliari
activ
possibl
role
virul
ferret
nasal
turbin
ex
vivo
tissu
use
compar
infect
influenza
virus
exhibit
divers
transmiss
phenotyp
context
assess
inhibitor
effect
nasal
mucou
other
identifi
mucinsecret
submucos
gland
ferret
respiratori
tract
express
sialyl
glycan
context
olink
glycan
predomin
receptor
human
influenza
virus
propos
proxim
viru
site
mucou
secret
possibl
mechan
enhanc
aerosol
transmiss
viru
addit
ex
vivo
imag
entir
respiratori
tract
ferret
provid
visual
viru
deposit
pattern
inocul
studi
provid
insight
influenza
virus
deposit
attach
replic
possibl
transmit
respiratori
tract
tissu
vitro
ex
vivo
model
system
attract
methodolog
address
question
tissu
tropism
immun
respons
viru
replic
independ
whole
host
system
howev
wholesystem
approach
advantag
allow
assess
viru
replic
immun
respons
context
divers
virul
transmiss
phenotyp
display
infect
host
human
influenza
challeng
studi
conduct
improv
polici
infect
prevent
intervent
natur
experiment
rang
studi
limit
necessit
need
anim
model
infect
nonhuman
primat
nhp
use
recapitul
influenza
viru
infect
human
despit
relev
nhp
human
expens
inher
ethic
issu
limit
broad
util
anim
model
thu
small
anim
routin
use
influenza
viru
research
although
mani
mammalian
model
evalu
anim
often
use
model
influenza
viru
infect
mice
guinea
pig
ferret
mice
use
extens
assess
pathogenesi
immun
respons
vaccin
efficaci
even
though
human
influenza
virus
typic
requir
prior
adapt
anim
model
knockout
mous
model
particularli
use
studi
specif
host
respons
vivo
set
advantag
share
model
guinea
pig
proven
use
outbr
model
studi
influenza
viru
transmiss
recent
innov
model
system
provid
opportun
evalu
effect
environment
condit
transmiss
influenza
virus
transmiss
viru
air
among
guinea
pig
effici
cool
dri
environ
regardless
rel
humid
condit
abolish
shortcom
model
guinea
pig
lack
mani
clinic
sign
found
human
follow
influenza
viru
infect
make
difficult
assess
virul
howev
infect
fatal
observ
certain
strain
influenza
viru
mice
ferret
use
studi
particular
diseas
paramet
treatment
strategi
may
otherwis
possibl
ferret
becom
model
choic
mani
influenza
viru
research
laboratori
despit
gener
lack
avail
immunolog
reagent
outbr
ferret
highli
suscept
influenza
viru
infect
without
prior
adapt
viru
exhibit
clinic
sign
similar
infect
human
display
gener
transmiss
phenotyp
influenza
virus
report
human
studi
demonstr
similar
distribut
influenza
viru
receptor
pva
ferret
respiratori
tract
tissu
compar
human
provid
evid
suitabl
ferret
model
influenza
viru
infect
respiratori
droplet
transmiss
model
develop
ferret
identifi
influenza
virus
capabl
transmit
air
respiratori
droplet
may
consist
larger
droplet
smaller
droplet
nuclei
term
refer
transmiss
viru
air
absenc
direct
indirect
contact
anim
critic
inform
regard
molecular
correl
virul
transmiss
influenza
virus
gain
use
ferret
provid
genet
marker
earli
detect
influenza
virus
potenti
caus
diseas
transmit
readili
among
peopl
influenza
viru
infect
accur
model
laboratori
anim
understand
composit
respiratori
secret
pass
one
host
next
critic
aerosol
play
key
role
transmiss
influenza
virus
among
peopl
sever
environment
host
viral
factor
directli
influenc
size
number
aerosol
expel
infect
individu
subsequ
deposit
respiratori
tract
suscept
host
studi
conduct
use
human
volunt
show
tidal
breath
major
exhal
aerosol
mm
reach
concentr
particlesl
substanti
rang
person
person
influenza
viru
detect
exhal
aerosol
size
peopl
larg
limit
detect
viral
rna
demonstr
presenc
influenza
viral
materi
respir
aerosol
particl
need
improv
method
preserv
viru
viabil
sampl
aerosol
aerosol
shed
profil
evalu
ferret
model
similarli
major
aerosol
exhal
ferret
tidal
breath
sneez
mm
sever
air
sampl
devic
evalu
abil
isol
preserv
infect
influenza
viru
aerosol
recent
studi
skc
biosampl
use
liquid
medium
aerosol
collect
maintain
viru
viabil
better
filterbas
sampler
howev
devic
provid
size
fraction
aerosol
nation
institut
occup
safeti
health
develop
twostag
cyclon
bioaerosol
sampler
separ
aerosol
size
mm
recent
report
improv
method
enhanc
viabl
viru
recoveri
nebulizergener
aerosol
recoveri
devic
use
measur
influenza
viru
aerosol
gener
individu
cough
detect
viral
rna
prove
review
trend
microbiolog
june
vol
much
reliabl
recoveri
viabl
viru
howev
enhanc
detect
method
viabl
viru
use
studi
sampl
devic
use
ferret
transmiss
studi
detect
influenza
viral
rna
respir
aerosol
exhal
ferret
allow
identif
viral
genet
factor
associ
transmiss
viru
air
use
anoth
sampl
devic
cascad
impactor
modifi
procedur
viabl
viru
detect
respir
aerosol
particl
collect
tidal
breath
sneez
recoveri
rate
estim
figur
although
variabl
among
ferret
infecti
viru
shed
detect
plaqu
form
unit
pfu
l
normal
breath
devic
updat
procedur
describ
studi
repres
innov
bioaerosol
sampl
enhanc
abil
understand
composit
aerosol
shed
peopl
anim
model
infect
influenza
virus
transmit
air
deposit
aerosol
particl
human
respiratori
tract
extens
studi
occur
via
sever
mechan
affect
factor
aerosol
size
concentr
composit
breath
rate
tidal
volum
gener
particl
mm
deposit
urt
passag
particl
mm
deposit
tracheobronchi
region
aerosol
mm
capabl
reach
bronchiol
alveoli
anim
model
aerosol
deposit
use
inhal
toxicolog
physiolog
drug
deliveri
studi
despit
appar
anatom
differ
compar
human
valuabl
inform
extrapol
larg
anim
model
like
nhp
also
rodent
speci
ferret
advanc
molecular
imag
technolog
facilit
visual
deposit
pattern
influenza
viru
inocul
procedur
ferret
well
bacteri
pneumonia
relat
influenza
viru
infect
mice
use
techniqu
character
aerosol
exhal
deposit
respiratori
tract
laboratori
anim
instrument
develop
relev
method
inocul
inocul
laboratori
anim
influenza
virus
accomplish
use
varieti
techniqu
depend
question
address
far
method
use
frequent
administr
liquid
viru
suspens
directli
respiratori
tract
notabl
intranas
instil
nare
anim
method
becom
standard
practic
among
influenza
viru
laboratori
use
rang
volum
depend
anim
model
region
respiratori
tract
target
reduc
volum
may
use
avoid
deliv
substanti
portion
inoculum
lrt
howev
caveat
intranas
inocul
portion
inoculum
may
swallow
divert
away
respiratori
tract
anim
may
swallow
inocul
procedur
altern
intratrach
inocul
may
use
bypass
urt
gastrointestin
tract
allow
research
observ
differ
diseas
paramet
may
associ
rout
inocul
studi
use
ocular
inocul
provid
evid
replicationindepend
spread
viru
eye
respiratori
tract
occur
like
via
lacrim
nasolacrim
duct
ocular
tissu
also
support
influenza
viru
replic
studi
like
demonstr
method
inocul
import
compon
experiment
design
import
advantag
establish
method
inocul
close
mimic
natur
rout
infect
administr
liquid
inoculum
repres
influenza
viru
infect
occur
natur
mani
studi
present
either
epidemiolog
experiment
deriv
data
conclud
droplet
aerosol
involv
influenza
viru
transmiss
human
anim
model
aerosol
exposur
anim
model
mice
guinea
pig
ferret
influenza
viru
describ
studi
mice
show
compar
intranas
inocul
aerosol
deliveri
influenza
viru
caus
increas
morbid
mortal
aerosol
deliveri
antivir
liveattenu
influenza
vaccin
viru
effect
method
diseas
prevent
anim
model
guinea
pig
inocul
aerosol
season
influenza
viru
reportedli
contagi
inocul
intranas
ferret
inocul
aerosol
hpai
viru
exhibit
earlier
onset
broader
spectrum
diseas
compar
intranas
inocul
wherea
ferret
inocul
aerosol
season
influenza
viru
exhibit
ill
indistinguish
natur
acquir
infect
specif
ferret
infect
exposur
infect
ferret
similar
viru
shed
kinet
diseas
characterist
note
compar
lowdos
aerosol
inocul
ferret
moreov
ferret
infecti
dose
season
influenza
viru
deliv
via
aerosol
pfu
focu
formingunit
similar
human
infecti
dose
aerosoldeliv
influenza
viru
tissu
cultur
infecti
dose
provid
addit
support
relev
aerosol
method
inocul
ferret
model
influenza
viru
infect
although
studi
requir
special
instrument
describ
within
note
refer
demonstr
applic
aerosol
inocul
influenza
viru
research
bioaerosol
exposur
system
individu
meet
specif
experiment
need
valid
bioaerosol
system
conduct
prior
anim
exposur
ensur
consist
reliabl
deliveri
present
dose
anim
consider
given
bioaerosol
shed
profil
infect
host
environment
condit
model
innov
inoculum
deliveri
method
provid
improv
anim
model
influenza
viru
infect
pathogenesi
transmiss
close
recreat
natur
airborn
infect
laboratori
set
past
year
techniqu
experiment
research
develop
facilit
improv
understand
respiratori
virus
particular
influenza
virus
caus
diseas
spread
human
popul
advanc
would
possibl
without
abil
model
respiratori
viru
infect
laboratori
despit
advanc
mani
limit
still
exist
regardless
close
respiratori
infect
recreat
anim
model
never
provid
exact
represent
infect
human
complic
often
unpredict
behavior
environment
influenc
govern
interact
peopl
environment
condit
respiratori
virus
spread
scenario
accommod
control
laboratori
set
continu
evalu
environment
paramet
affect
respiratori
pathogen
feasibl
result
ethic
conduct
human
studi
provid
continu
improv
anim
model
procedur
use
recreat
respiratori
infect
laboratori
applic
aerobiolog
techniqu
anim
model
influenza
viru
infect
deliveri
aerosol
inocula
character
aerosol
shed
import
step
end
manipul
size
composit
aerosol
inocula
deliv
anim
model
offer
opportun
better
understand
mechan
involv
variou
mode
transmiss
perform
experi
wellcontrol
review
trend
microbiolog
june
vol
condit
accur
reflect
indoor
outdoor
environ
temper
tropic
region
provid
relev
understand
behavior
exhal
respiratori
secret
stabil
respiratori
pathogen
transmit
research
continu
make
innov
stride
infecti
diseas
experiment
research
biosafeti
biosecur
undoubtedli
forefront
discuss
care
consider
potenti
dual
use
applic
risk
versu
benefit
public
health
via
inform
share
undertaken
scientif
public
health
commun
nevertheless
studi
aim
improv
knowledg
pathogenesi
transmiss
respiratori
virus
facilit
advanc
current
treatment
prevent
strategi
aid
develop
new
antivir
vaccin
broad
coverag
lessen
diseas
burden
human
popul
